Background The coronavirus disease 2019 (COVID-19) pandemic has led to a public health
crisis. Only limited data are available on the characteristics and outcomes of patients …

A common and potent consideration has recently entered the landscape of the novel
coronavirus disease of 2019 (COVID-19): venous thromboembolism (VTE). COVID-19 has …

Background Venous thromboembolism (VTE)(pulmonary embolism [PE] or deep venous
thrombosis [DVT]) is common during acute COVID-19. Long-term excess risk has not yet …

Acute respiratory distress syndrome (ARDS) caused by coronavirus disease (COVID-
19)(CARDS) has similarities and differences compared with ARDS from other etiologies (1) …

Scientific research continues on new preventive and therapeutic strategies against severe
acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). So far, there is no proven curative …

Objective Pulmonary embolism (PE) is a common complication of SARS-CoV-2 infection.
Several diagnostic prediction rules based on pretest probability and D-dimer have been …

Importance Given the high risk of thrombosis and anticoagulation-related bleeding in
patients with hypoxemic COVID-19 pneumonia, identifying the lowest effective dose of …

Coronavirus disease 2019 (COVID-19) increases the risk of thromboembolic events,
especially in patients with severe infections requiring intensive care and cardiorespiratory …

Background An understanding of differences in clinical phenotypes and outcomes COVID-
19 compared with other respiratory viral infections is important to optimise the management …

Aims Although cardiac involvement has prognostic significance in coronavirus disease 2019
(COVID-19) and is associated with severe forms, few studies have explored the prognostic …